WHO emergency approval for Covaxin delayed till October 5
- 3 years ago
World Health Organisation's (WHO) approval for the emergency use authorisation (EUA) to Covid-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to be delayed till October 5.
As per WHO, the Strategic Advisory Group of Experts on Immunization (SAGE) will be meeting on October 5 to grant EUA to Covaxin.
As per WHO, the Strategic Advisory Group of Experts on Immunization (SAGE) will be meeting on October 5 to grant EUA to Covaxin.